Celldex Therapeutics DPO Ratio 2011-2026 | CLDX

Annual DPO Ratio Celldex Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.06 K	6.17 K	4.16 K	8.34 K	4.15 K	2.03 K	-	-	-	-	-	-	351	25.2	37.4

All numbers in USD currency

Maximum	Minimum	Average
8.34 K	25.2	3.26 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	395	$ 4.14	0.36 %	$ 443 M	USA
Ardelyx ARDX	163	$ 6.06	1.94 %	$ 1.46 B	USA
Arcutis Biotherapeutics ARQT	133	$ 23.83	0.85 %	$ 3.03 B	USA
Aytu BioScience AYTU	186	$ 2.65	-1.12 %	$ 16.6 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
BioCardia BCDA	68.1 K	$ 1.2	-0.04 %	$ 8 M	USA
BioCryst Pharmaceuticals BCRX	484	$ 9.6	6.37 %	$ 1.98 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	199	$ 9.48	-3.27 %	$ 613 M	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
BioMarin Pharmaceutical BMRN	245	$ 56.49	1.78 %	$ 10.8 B	USA
BioXcel Therapeutics BTAI	34.2 K	$ 1.16	-2.12 %	$ 14.2 M	USA
Catalyst Biosciences CBIO	7.82	$ 19.97	2.94 %	$ 1.78 B	USA
Codexis CDXS	85.8	$ 1.97	7.97 %	$ 172 M	USA
Cerus Corporation CERS	242	$ 1.91	2.42 %	$ 364 M	USA
Coherus BioSciences CHRS	507	$ 1.75	0.87 %	$ 205 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain